Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 19671774)

  • 1. Metastatic colorectal cancer: is surgery necessary?
    Schmidt C
    J Natl Cancer Inst; 2009 Aug; 101(16):1113-5. PubMed ID: 19671774
    [No Abstract]   [Full Text] [Related]  

  • 2. [End results of combined treatment in metastatic colorectal cancer].
    Polysalov VN; Rutkin IO; Krotova OA; Tlostanova MS
    Vopr Onkol; 2011; 57(2):265-9. PubMed ID: 21809678
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases.
    Masi G; Loupakis F; Pollina L; Vasile E; Cupini S; Ricci S; Brunetti IM; Ferraldeschi R; Naso G; Filipponi F; Pietrabissa A; Goletti O; Baldi G; Fornaro L; Andreuccetti M; Falcone A
    Ann Surg; 2009 Mar; 249(3):420-5. PubMed ID: 19247029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
    Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
    Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of systemic therapy for metastatic colorectal cancer.
    Geh JI; Ma YT
    Colorectal Dis; 2011 Aug; 13(8):852-4. PubMed ID: 21762349
    [No Abstract]   [Full Text] [Related]  

  • 6. Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.
    Dohn LH; Jensen BV; Larsen FO
    Acta Oncol; 2010 Apr; 49(3):395-6. PubMed ID: 20001495
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.
    Ayez N; van der Stok EP; Grünhagen DJ; Rothbarth J; van Meerten E; Eggermont AM; Verhoef C
    Eur J Surg Oncol; 2015 Jul; 41(7):859-67. PubMed ID: 25979624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical therapies in metastatic colorectal cancer with a potential for cure.
    Chua TC; Liauw W; Koong HN; Esquivel J
    Am J Clin Oncol; 2011 Jun; 34(3):326-31. PubMed ID: 20498587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of unresectable metastatic colorectal cancer: does "adjuvant" chemotherapy play a role after resection?
    Power DG; Kemeny NE
    Ann Surg; 2009 Oct; 250(4):654-5; author reply 655. PubMed ID: 19730229
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.
    Dexiang Z; Li R; Ye W; Haifu W; Yunshi Z; Qinghai Y; Shenyong Z; Bo X; Li L; Xiangou P; Haohao L; Lechi Y; Tianshu L; Jia F; Xinyu Q; Jianmin X
    Ann Surg Oncol; 2012 Sep; 19(9):2860-8. PubMed ID: 22526903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.
    Allegra C; George T; Yothers G
    J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgical adjuvant therapy for colorectal cancer: current approaches and future directions.
    Monga DK; O'Connell MJ
    Ann Surg Oncol; 2006 Aug; 13(8):1021-34. PubMed ID: 16897272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should the results of the new EPOC trial change practice in the management of patients with resectable metastatic colorectal cancer confined to the liver?
    Nordlinger B; Poston GJ; Goldberg RM
    J Clin Oncol; 2015 Jan; 33(3):241-3. PubMed ID: 25403221
    [No Abstract]   [Full Text] [Related]  

  • 14. Current status of adjuvant therapy for colorectal cancer.
    O'Connell MJ
    Oncology (Williston Park); 2004 May; 18(6):751-5; discussion 755-8. PubMed ID: 15214594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver resection after downstaging with neoadjuvant chemotherapy for "unresectable" colorectal metastases].
    Frena A; Martin F; La Guardia G; Vezzali N; Bonatti G; Stocker J; Graiff C
    Chir Ital; 2004; 56(3):351-7. PubMed ID: 15287631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategy for synchronous and multiple liver metastasis.
    Osada S; Imai H; Sasaki Y; Tanaka Y; Tokuyama Y; Okumura N; Nonaka K; Takahashi T; Yamaguchi K; Yoshida K
    Hepatogastroenterology; 2012; 59(113):198-203. PubMed ID: 22251539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view.
    Battisti S; Guida FM; Pagliara E; Tonini G; Zobel BB; Santini D
    Clin Colorectal Cancer; 2014 Sep; 13(3):e13-5. PubMed ID: 25085312
    [No Abstract]   [Full Text] [Related]  

  • 18. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.
    Tamandl D; Klinger M; Eipeldauer S; Herberger B; Kaczirek K; Gruenberger B; Gruenberger T
    Ann Surg Oncol; 2011 Feb; 18(2):421-30. PubMed ID: 20844968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy.
    Small RM; Lubezky N; Shmueli E; Figer A; Aderka D; Nakache R; Klausner JM; Ben-Haim M
    J Surg Oncol; 2009 Feb; 99(2):93-8. PubMed ID: 19065637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of capecitabine and oxaliplatin in metastatic colorectal cancer.
    Clin Colorectal Cancer; 2003 Feb; 2(4):205-9. PubMed ID: 12620138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.